Fundamental studies on the mechanism of action of a novel sirtuin inhibitor (BZD9L 1) in colorectal cancer cells- towards the elucidation of a novel cancer therapeutic agent.

Oon , Chern Ein (2016) Fundamental studies on the mechanism of action of a novel sirtuin inhibitor (BZD9L 1) in colorectal cancer cells- towards the elucidation of a novel cancer therapeutic agent. Technical Report. Universiti Sains Malaysia.

Full text not available from this repository.

Abstract

Gemcitabine remains the standard treatment for pancreatic cancer. although most patients acquire resistance to the therapy. Up-regulated in pancreatic cancer. SIRTI is involved in tumorigenesis and drug resistance, However the mechanism through which SIRTl regulates drug sensitivity in cancer cells is mainly unknown.

Item Type: Monograph (Technical Report)
Subjects: R Medicine > R Medicine (General) > R735-854 Medical education. Medical schools. Research
Divisions: Institut Penyelidikan Perubatan Molekul (Institute for Research in Molecular Medicine INFORMM) > Monograph
Depositing User: Mr Erwan Roslan
Date Deposited: 03 Oct 2017 16:13
Last Modified: 03 Oct 2017 16:13
URI: http://eprints.usm.my/id/eprint/36903

Actions (login required)

View Item
Share